Home >> Tag Archives: Beckman Coulter—

Tag Archives: Beckman Coulter—

Beckman releases DxM MicroScan

September 2018—Beckman Coulter announced commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing that uses direct minimum inhibitory concentrations for detection of antimicrobial resistance.

Read More »

Beckman releases new version of middleware

Sept. 12, 2018–Beckman Coulter launched version 1.10 of its Remisol Advance middleware system for mid- to high-volume laboratories. Enhancements include a centralized dashboard that combines sample status information (pending, stat, validated, and processed), turnaround time data, and quality control alerts in an intuitive format. “By providing a snapshot display of important analytics in a single location, we are enabling technologists ...

Read More »

Beckman releases DxM MicroScan

Aug. 7, 2018—Beckman Coulter announced commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing that uses direct minimum inhibitory concentrations for detection of antimicrobial resistance. The system’s delivery of gold-standard MIC accuracy helps laboratories achieve their operational goals by reducing costs associated with confirmatory testing, the company says. Added workflow enhancements include ...

Read More »

Beckman Coulter, Arkray launch iQ Workcell

Aug. 1, 2018—Beckman Coulter and U.S. Arkray announced a partnership and the launch of the iQ Urinalysis Workcell, which pairs Beckman’s Iris iQ200 Digital Flow Morphology system with the Arkray Aution Max AX-4030 fully automated urine analyzer. The iQ Urinalysis Workcell will be available in the U.S. exclusively through Beckman Coulter; the company will also offer the Aution Max AX-4030 ...

Read More »

Beckman’s Early Sepsis Indicator gets CE mark

July 2018—Beckman Coulter announced its Early Sepsis Indicator received the CE mark. The Early Sepsis Indicator is a hematology-based solution designed to alert emergency department clinicians to the possibility of sepsis or risk of developing sepsis and is to be offered as part of a routine CBC with differential test.

Read More »

Study: blood tests effective in screening for OSA

June 22, 2018—Beckman Coulter announced the results of a clinical trial suggesting that blood tests may offer benefits in the initial screening for obstructive sleep apnea. The study, which involved 264 male adult patients from six institutions, revealed that screening for changes in three specific biomarkers–hemoglobin A1c, C-reactive protein, and erythropoietin–may be useful in helping identify obstructive sleep apnea. The results ...

Read More »
X